SCI Abstract

search
+
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function
IntroductionEvidence from basic research and clinical trials demonstrates that the interleukin (IL) 17 immune axis exerts ...
Annals of the Rheumatic Diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers
Annals of the Rheumatic Diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers
IntroductionAutoimmunity is central to the pathogenesis of many rheumatic diseases and has therefore been the focus of man...
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease
IntroductionCalcium pyrophosphate deposition (CPPD) disease is a common symptomatic arthritis characterised by the deposit...
2023 ACR/EULAR antiphospholipid syndrome classification criteria
2023 ACR/EULAR antiphospholipid syndrome classification criteria
IntroductionAntiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by arterial, venous, or microva...
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
Mathian et al described the clinical course and heterogeneity of COVID-19 in 17 systemic lupus erythematosus (SLE) patient...
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
WHAT IS ALREADY KNOWN ON THIS TOPICWHAT THIS STUDY ADDSFor the first time, three biologics with different modes of action,...
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Cost-utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands
Cost-utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares
Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares
ResultsGut dysbiosis is pronounced in patients with high disease activityTo study the gut microbial communities in sequent...
Single-cell transcriptome analysis profiles cellular and molecular alterations in submandibular gland and blood in IgG4-related disease
Single-cell transcriptome analysis profiles cellular and molecular alterations in submandibular gland and blood in IgG4-related disease
AbstractObjectives The aim of this study is to profile the transcriptional landscapes of affected tissues and peripheral b...
Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020
Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
The article of interest entitled ‘Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: ...
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study
IntroductionIn December 2019, SARS-CoV-2 was reported as the infectious agent leading to COVID-19.1 Globally, >762 mill...
Rare mimicker of sacroiliitis
Rare mimicker of sacroiliitis
A 62-year-old woman was referred for suspected sacroiliitis discovered incidentally on a CT scan performed for pre-transpl...
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
Systematic literature reviewBriefly, original research articles of any study design with diagnosis, treatment and monitori...
Correction: Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis
Correction: Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis
Gao H, Liu S, Mai Y, et al. Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibro...
Correspondence to 'Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection--a missing link for ACPA production
Correspondence to 'Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection--a missing link for ACPA production
With great interest, we read the work by Jenning et al, which proposed a mechanism by which Porphyromonas gingivalis (P.g....
Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study
Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study
With great interest, we read the recently published report by Greenwood et al in which the benefits of coprescription of m...
Correspondence on 'Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases
Correspondence on 'Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases
We read with great interest the article by Ter Haar et al 1 who describe the clinical characteristics, treatment response ...
Correction: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label randomised controlled ORAL Surveillance trial
Correction: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label randomised controlled ORAL Surveillance trial
Balanescu AR, Citera G, Pascual-Ramos V, et al. Infections in patients with rheumatoid arthritis receiving tofacitinib ver...
Correspondence on 'The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series
Correspondence on 'The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series
We read with great interest the article ‘The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infe...
Autoantibodies identify primary Sjögrens syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B
Autoantibodies identify primary Sjögrens syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases
We followed with great interest the numerous reports published by the Annals 1–9 as regards the impact of the COVID-19 pan...
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease
Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease
IgG4-related disease (IgG4-RD) is a multisystem fibroinflammatory disorder diagnosed and managed across a broad spectrum o...
Extracellular aaRSs drive autoimmune and inflammatory responses in rheumatoid arthritis via the release of cytokines and PAD4
Extracellular aaRSs drive autoimmune and inflammatory responses in rheumatoid arthritis via the release of cytokines and PAD4
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Correspondence on "Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis"
Correspondence on "Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis"
The article titled ‘Isolation of HLA-DR naturally presented peptides identifies T cell epitopes for rheumatoid arthritis’ ...
Response to: Correspondence on "HLA-DR 'naturally presented peptides: you will find what you have pulsed with" by Roudier
Response to: Correspondence on "HLA-DR 'naturally presented peptides: you will find what you have pulsed with" by Roudier
We appreciate Dr Roudier’s interest and comment on our recent article.1 2 The aim of our study was to analyse the human le...
Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"
Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"
With great interest I read the recently published Assessment of Spondyloarthritis International Society (ASAS/European All...
Load More
format_indent_increase